T1	Participants 343 414	Japanese patients with lower urinary tract symptoms associated with BPH
T2	Participants 824 858	102 patients (mean age 70.3 years)
T3	Participants 984 1099	patients who preferred tamsulosin (59/84 patients; 70.2%) and those who preferred silodosin (18/84 patients; 21.4%)
T4	Participants 1225 1301	tamsulosin (3/91 patients; 3.3%) than with silodosin (25/88 patients; 28.4%)
